Status:
WITHDRAWN
Isopropyl Alcohol Inhalation as Anti-emetic Therapy in the Emergency Department
Lead Sponsor:
Ottawa Hospital Research Institute
Conditions:
Nausea
Vomiting
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Nausea and vomiting is a common and distressing presenting complaint in Canadian emergency departments. Commonly used nausea medications have proven to be effective in certain patient populations, for...
Detailed Description
BACKGROUND INFORMATION: Emerging evidence exists supporting the use of nasally inhaled isopropyl alcohol swabs as anti-emetic therapy. Multiple studies report isopropyl alcohol inhalation as an effec...
Eligibility Criteria
Inclusion
- Adult patients (age ≥18 years) presenting to the emergency department with a chief complaint of nausea and/or vomiting with a level of 3 or greater on a verbal numeric response scale (1-10).
Exclusion
- Not able to breathe through nares (ie. rhinitis)
- Known pregnancy
- Have already received an anti-emetic within the past 24 hours (including while in emergency department triage)
- Chronic nausea (\> 1 month)
- Known allergy to isopropyl alcohol
- Nasally sensitive to inhaled chemical products
- Altered mental status or underlying cognitive impairment
Key Trial Info
Start Date :
July 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2020
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT04464915
Start Date
July 1 2020
End Date
November 1 2020
Last Update
September 30 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Ottawa Hospital
Ottawa, Ontario, Canada, K1Y 4E9